CoChat

Glucocorticoids regulate arrestin gene expression and redirect the signaling profile of G protein-coupled receptors

Open access
Oakley, Robert H., Revollo, Javier, Cidlowski, John A. · 2012 · Proceedings of the National Academy of Sciences

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Abstract

G protein-coupled receptors (GPCRs) compose the largest family of cell surface receptors and are the most common target of therapeutic drugs. The nonvisual arrestins, β-arrestin-1 and β-arrestin-2, are multifunctional scaffolding proteins that play critical roles in GPCR signaling. On binding of activated GPCRs at the plasma membrane, β-arrestins terminate G protein-dependent responses (desensitization) and stimulate β-arrestin-dependent signaling pathways. Alterations in the cellular complement of β-arrestin-1 and β-arrestin-2 occur in many human diseases, and their genetic ablation in mice has severe consequences. Surprisingly, however, the factors that control β-arrestin gene expression are poorly understood. We demonstrate that glucocorticoids differentially regulate β-arrestin-1 and β-arrestin-2 gene expression in multiple cell types. Glucocorticoids act via the glucocorticoid receptor (GR) to induce the synthesis of β-arrestin-1 and repress the expression of β-arrestin-2. Glucocorticoid-dependent regulation involves the recruitment of ligand-activated glucocorticoid receptors to conserved and functional glucocorticoid response elements in intron-1 of the β-arrestin-1 gene and intron-11 of the β-arrestin-2 gene. In human lung adenocarcinoma cells, the increased expression of β-arrestin-1 after glucocorticoid treatment impairs G protein-dependent activation of inositol phosphate signaling while enhancing β-arrestin-1-dependent stimulation of the MAPK pathway by protease activated receptor 1. These studies demonstrate that glucocorticoids redirect the signaling profile of GPCRs via alterations in β-arrestin gene expression, revealing a paradigm for cross-talk between nuclear and cell surface receptors and a mechanism by which glucocorticoids alter the clinical efficacy of GPCR-based drugs.

Overview

Integrity signals

Registry

Crossref · 10.1073/pnas.1209411109

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 55

Metadata

Authors
Oakley, R. H., Revollo, J., & Cidlowski, J. A.
Affiliations
National Institutes of Health (US)
Venue
Proceedings of the National Academy of Sciences
Published
2012-10-08
Volume
109
Issue
43
Pages
17591-17596
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W1974786948
Cited by
55
References
26
Citations by year
2026: 1 · 2025: 4 · 2024: 4 · 2023: 2 · 2022: 5 · 2021: 5 · 2020: 4 · 2019: 6 · 2018: 8 · 2017: 4 · 2016: 4 · 2015: 1 · 2014: 3 · 2013: 4
FWCI
1.03
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institutes of Health
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
Keywords
glucocorticoids, β-arrestin1, β-arrestin2, G protein-coupled receptors, glucocorticoid receptor, gene expression regulation, glucocorticoid response element, receptor desensitization, MAPK signaling, protease-activated receptor 1, inositol phosphate signaling, lung adenocarcinoma cells
MeSH terms
beta-Arrestins, beta-Arrestin 1, beta-Arrestin 2, Gene Expression Regulation, Glucocorticoids, Humans, RNA, Messenger, Signal Transduction, Arrestins, Reverse Transcriptase Polymerase Chain Reaction, Receptors, G-Protein-Coupled, Cell Line, Tumor, Chromatin Immunoprecipitation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.